Back
Recursion Pharmaceuticals Stock Predictions
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
RXRX
Recursion Pharmaceuticals
Last Price:
$5.49
Seasonality Move:
31.28%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Recursion Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 24.2% based on the past 4 years of stock performance.
-
Recursion Pharmaceuticals has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Recursion Pharmaceuticals Stock Undervalued?The current Recursion Pharmaceuticals [RXRX] share price is $5.32. The Score for RXRX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 24.2% based on the past 4 years of stock performance.
Recursion Pharmaceuticals Stock Rating
Sell
21
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals overpriced?
-
Recursion Pharmaceuticals has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Recursion Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
12.36
52-Week Low:
3.79
Prediction Charts
Market Cap:
2.1B
Price in USD:
5.32
Volume:
15.7M
Beta:
1.00
Technical Analysis
SMA50:
6.77
SMA100:
6.86
SMA200:
6.94
52-Wk Change:
-29.72%
Stock Predictions
-
Is Recursion Pharmaceuticals stock public?Yes, Recursion Pharmaceuticals is a publicly traded company.
-
What is the Recursion Pharmaceuticals stock quote today?The Recursion Pharmaceuticals stock price is 5.32 USD today.
-
How to buy Recursion Pharmaceuticals stock online?You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-28 | 5.95 | 5.81 | 6.01 | 5.77 |
| Mar-31 | 5.50 | 5.29 | 5.51 | 5.19 |
| Apr-1 | 5.32 | 5.10 | 5.34 | 5.00 |
| Apr-2 | 4.99 | 5.29 | 5.37 | 4.95 |
| Apr-3 | 4.91 | 4.81 | 5.03 | 4.78 |
| Apr-4 | 4.59 | 4.24 | 4.74 | 4.06 |
| Apr-7 | 3.96 | 4.20 | 4.60 | 3.80 |
| Apr-8 | 4.49 | 3.97 | 4.49 | 3.87 |
| Apr-9 | 3.89 | 4.65 | 4.97 | 3.79 |
| Apr-10 | 4.60 | 4.51 | 4.64 | 4.07 |
| Apr-11 | 5.00 | 5.76 | 6.00 | 4.86 |
| Apr-14 | 5.94 | 5.51 | 5.96 | 5.25 |
| Apr-15 | 5.55 | 5.64 | 5.89 | 5.46 |
| Apr-16 | 5.45 | 5.32 | 5.56 | 5.14 |
Recursion Pharmaceuticals Earnings
Recursion Pharmaceuticals Earnings Report: Per Share Recursion Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Recursion Pharmaceuticals Forecast Revenue Growth
Recursion Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Recursion Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.17 per share, a decrease this year of $0.07 per share, and an increase next year of $0.27 per share.
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.